TNFRSF4 and acute myeloid leukemia: In terms of patients’ age and disease origin (primary vs secondary AML), a higher expression of OX40 was identified in primary AML only with regards to SFI (Figure S1), while the frequencies of positive cells were found to be homogeneous for both markers in each group of patients.